- In April 2024, SCHOTT AG announced that its skin-friendly bioactive glass powder, Vitryxx, can serve as an ammonia alternative in permanent hair dyes. This innovative application marks a significant expansion of bioactive glass into the cosmetics and personal care sector. Vitryxx is odorless, pH-boosting, and highly biocompatible, offering a gentler alternative to traditional alkalizing agents such as ammonia and 2-ethanolamine, which are known for their pungent odor and potential to irritate the skin. This development highlights the versatility of bioactive glass and SCHOTT’s commitment to sustainable and skin-friendly solutions beyond medical applications
- In October 2023, BonAlive Biomaterials expanded its innovative portfolio by launching bioactive glass granules specifically tailored for the chronic wound care market. These granules are based on the company’s proprietary S53P4 bioactive glass technology, which is known for its ability to inhibit bacterial growth and stimulate tissue regeneration. This launch marks BonAlive’s strategic move beyond bone regeneration into advanced wound healing, addressing the rising global demand for antibiotic-free, regenerative solutions. The product reinforces BonAlive’s leadership in the bioactive glass sector and supports its mission of enabling “Smart Healing” in complex clinical scenarios
- In November 2023, SCHOTT AG unveiled a new advanced composition of bioactive glass specifically engineered to enhance outcomes in spinal surgery. This innovation is part of SCHOTT’s broader commitment to advancing biomaterial technologies that improve patient recovery and surgical success rates. The newly developed bioactive glass formulation is designed to promote bone regeneration, reduce infection risks, and integrate seamlessly with the body’s natural healing processes. By targeting spinal applications, SCHOTT reinforces its position as a leader in high-performance medical materials, addressing the growing demand for next-generation solutions in orthopedics and neurosurgery
- In October 2023, NovaBone Products expanded its orthopedic portfolio by launching new bioactive putties designed to enhance bone regeneration and surgical outcomes in orthopedic procedures. These putties are formulated with Calcium Sodium Phosphosilicate (Bioglass) and a synthetic binder, offering osteostimulative properties that promote natural bone healing. The products are engineered for ease of use, with excellent handling characteristics that allow precise placement in bone defects. This development reinforces NovaBone’s commitment to advancing synthetic bone graft technologies and supporting improved patient care in orthopedic surgery
- In September 2023, Corning Incorporated announced plans to establish its first manufacturing facility in India, focused on producing Gorilla Glass for smartphones and other electronic devices. The facility, located in Telangana, represents a USD 113 million investment and is expected to create over 800 jobs. While the plant is not specifically for bioactive glass, this strategic expansion strengthens Corning’s manufacturing footprint in the Asia-Pacific region, potentially enabling future diversification into other advanced glass materials, including bioactive glass, to meet rising regional demand for biocompatible and high-performance materials
